Enhanced acetylcholine release from cells that have more 15-kDa proteolipid in their membrane, a constituent V-ATPase, and mediatophore.
Mediatophore is a protein that translocates acetylcholine (ACh) on calcium action. It is a homopolymer of a 15-kDa proteolipid that is also a constituent of the membrane sector of vacuolar H+-adenosine trisphosphatase (V-ATPase; vacuolar proton pump). Experiments on neuroblastoma cell lines (N18TG-2) that are deficient for ACh release and on cells that are competent for release, such as the glioma C6BU-1 or the N18TG-2/C6BU-1 fusion product NG108-15, show that there is a correlation between ACh release and the 15-kDa proteolipid content of the cell membrane. In another cell line, L-M(TK-), it has been possible to up-regulate ACh release and the membrane proteolipid content after treating the cells with dibutyryl-cyclic AMP or dexamethasone. As mediatophore translocates ACh and as V-ATPase may help vesicular ACh storage, it was interesting to determine the respective role of the two proteins in the observed correlation between release and proteolipid content. After blocking vesicular loading with vesamicol, we did not affect release from these cells, suggesting that the observed correlation may be attributed to mediatophore. The acquisition of an ACh release mechanism would then depend on the process that guides the proteolipid to the plasma membrane of the cell.
Laboratoire de Neurobiologie Cellulaire et Moléculaire, CNRS, Gif sur Yvette, France.
M
M
Israël
B
B
Lesbats
M
M
Tomasi
S
S
Ohkuma
D000109:Acetylcholine / Q000378:metabolism*; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology; D001692:Biological Transport / Q000187:drug effects / Q000502:physiology; D002462:Cell Membrane / Q000737:chemistry / Q000201:enzymology; D003907:Dexamethasone / Q000494:pharmacology; D005910:Glioma; D006822:Hybrid Cells / Q000737:chemistry / Q000201:enzymology; D051379:Mice; D009419:Nerve Tissue Proteins / Q000378:metabolism*; D009467:Neuromuscular Depolarizing Agents / Q000494:pharmacology; D010880:Piperidines / Q000494:pharmacology; D011510:Proteolipids / Q000032:analysis / Q000378:metabolism*; D017494:Proton Pumps / Q000378:metabolism; D006180:Proton-Translocating ATPases / Q000378:metabolism*; D051381:Rats; D025262:Vacuolar Proton-Translocating ATPases
D000893:Anti-Inflammatory Agents; D009419:Nerve Tissue Proteins; D009467:Neuromuscular Depolarizing Agents; D010880:Piperidines; D011510:Proteolipids; D017494:Proton Pumps; C050299:mediatophore; C006189:vesamicol; D003907:Dexamethasone; D025262:Vacuolar Proton-Translocating ATPases; D006180:Proton-Translocating ATPases; D000109:Acetylcholine